DREAM-CV LAB retweeted
Dr. Abhinav Sharma and Dr. Nadia Giannetti contribute to the CCC/CHF Society 2025 Guideline Update for the pharmacologic management of heart failure with nonreduced ejection fraction (LVEF > 40%).
@DREAMCVLAB1
onlinecjc.ca/article/S0828-2…
DREAM-CV LAB retweeted
Congratulations to RI-MUHC trainee Orhun Kose, who has won the CHF Alliance Trainee Award with work that will help patients with heart failure and other cardiometabolic diseases → tinyurl.com/3z5tuawh
DREAM-CV LAB retweeted
It’s day 2️⃣! We are #excited for another day of congress filled with science, discussions, clinical pearls, #HFA millionaire quiz 🏆 and lots of opportunities to meet old and new friends! ✨
Abhinav Sharma highlights why he is excited to be at #HeartFailure2023 #HFAMotions
DREAM-CV LAB retweeted
Découvrez le projet fascinant, @DREAMCVLAB1 et l’association de HOP Tech avec le Dr Abhinav Sharma, un chercheur du @cusm_muhc et @RIMUHC1 pour aider à prévenir le diabète de type 2 grâce à l’intelligence artificielle. Pour lire la suite @LP_LaPresse : bit.ly/3haA5Ye
DREAM-CV LAB retweeted
Plus tôt cette année, Abhinav Sharma, cardiologue et chercheur à l'IR-CUSM, a lancé le projet #DecideCV de détection précoce du diabète de type 2 à l’aide d’un bracelet connecté...
lapresse.ca/actualites/scien… @DREAMCVLAB1 @cusm_muhc @MUHCFoundation @MEDTEQ_CA
DREAM-CV LAB retweeted
🎧8 min to learn more about the DECIDE-CV program. A multi-disciplinary and collaborative project aimed at using #ArtificialIntelligence-based technologies to improve health outcomes for patients with type 2 #diabetes mellitus
👏Hop Tech @BoehringerCA @MUHCFoundation @DREAMCVLAB1
Dr. Abhinav Sharma joins @eliasmakos on @CJAD800 to discuss how artificial intelligence & machine learning are helping advance DECIDE-CV. An innovative partnership with Hop Tech, @BoehringerCA, @cusm_muhc, @DREAMCVLAB1 & @MEDTEQ_CA. Learn more: bit.ly/39U81nY
DREAM-CV LAB retweeted
Dr. Abhinav Sharma joins @eliasmakos on @CJAD800 to discuss how artificial intelligence & machine learning are helping advance DECIDE-CV. An innovative partnership with Hop Tech, @BoehringerCA, @cusm_muhc, @DREAMCVLAB1 & @MEDTEQ_CA. Learn more: bit.ly/39U81nY
DREAM-CV LAB retweeted
Renseignez-vous au sujet du programme #DECIDECV, un nouveau projet novateur optimisant l’IA pour améliorer les soins du #DT2 au Québec : bit.ly/3v1Uwul
@DREAMCVLAB1 @cusm_muhc @MUHCFoundation @MEDTEQ_CA
HOP Tech
DREAM-CV LAB retweeted
Learn more about the #DECIDECV program, a new innovative project using AI to improve #T2D care in Quebec: bit.ly/37DrTe7
@DREAMCVLAB1 @cusm_muhc @MUHCFoundation @MEDTEQ_CA
HOP Tech
DREAM-CV LAB retweeted
We are working together to innovate diabetes care in Quebec. Our new partnership with health industry leaders aims to better diagnose #type2diabetes with AI-powered tech. @DREAMCVLAB1 @cusm_muhc @MUHCFoundation @MEDTEQ_CA #HOPTech #DECIDECV
Learn more: bit.ly/3jPU7F9
DREAM-CV LAB retweeted
RAASi therapy is often prescribed to patients with cardiovascular disease, who are more at risk of severe COVID-19. When hospitalized for COVID-19, is it best to continue or discontinue RAASi? Find out in this new paper by Dr. Abhinav Sharma. @RIMUHC1 bit.ly/3gGo5K2
DREAM-CV LAB retweeted
Prospective evaluation of Amazon Alexa's ability to screen for risk factors and symptoms of COVID-19 suggests that this technology may be feasible.
Link from @ESC_Journals:
doi.org/10.1093/ehjdh/ztab05…
#Cardiology @JeffBezos @RenatoDLopes1 @RobertAvramMD @DCRINews @RIMUHC1
DREAM-CV LAB retweeted
Really enjoyed diving into #Diabetic phenotypes and exploring their spectrum of #Cardiovascular risks. Whether phenotypes can be used to guide treatment remains to be seen! link.springer.com/article/10… @DREAMCVLAB1 @CVC_UAlberta @JustinEzekowitz
DREAM-CV LAB retweeted
Working Group Look-In: Digital Health
Recently, the HFC aimed to evaluate RCTs that have quantified the impact of HF interventions using actigraphy. @CJCJournals @mfiuzat @DrNasrien @YaleHFdoc @mpsotka @coconnormd @DREAMCVLAB1 #Actigraphy
Read Here 👉: onlinecjc.ca/article/S0828-2…
















